Quick answerUse
new constipation or ischemic-colitis cues as an alosetron stop rule.
Why this is correctContinuing the drug or adding another bowel-slowing agent can worsen obstruction or ischemia.
Easy analogy or mental pictureBuild a medication-safety chain: identify the new cue, connect it to the drug mechanism or labeled limitation, stop preventable exposure, stabilize the client, and verify a measurable response.
Memory hookDrug, urgent cue, protective action, and reassessment endpoint.NCLEX decision ruleChoose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.
Why the other choices are wrongOptions that continue a suspect exposure, normalize a labeled danger cue, substitute an unauthorized dose, or delay escalation leave the client at risk.
References
1DailyMed: LOTRONEX (alosetron)Immediate discontinuation for constipation or ischemic-colitis symptoms